CB
SYNH

Cooke & Bieler’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Cooke & Bieler’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-1,882,572
Closed -$69.1M – 109
2022
Q4 		$69.1M Sell
1,882,572
-1,006,021
-35% -$39.8M 0.68% 59
2022
Q3 		$136M Buy
2,888,593
+51,865
+2% +$3.35M 1.46% 24
2022
Q2 		$203M Buy
2,836,728
+477,225
+20% +$34.9M 1.96% 12
2022
Q1 		$191M Buy
2,359,503
+663,152
+39% +$56.1M 1.68% 18
2021
Q4 		$174M Sell
1,696,351
-462,345
-21% -$44.4M 1.5% 20
2021
Q3 		$189M Sell
2,158,696
-32,595
-1% -$2.95M 1.71% 14
2021
Q2 		$196M Buy
2,191,291
+31,020
+1% +$2.62M 1.81% 14
2021
Q1 		$164M Buy
2,160,271
+88,440
+4% +$6.67M 1.59% 21
2020
Q4 		$141M Sell
2,071,831
-87,050
-4% -$5.43M 1.54% 19
2020
Q3 		$115M Sell
2,158,881
-44,090
-2% -$2.63M 1.53% 25
2020
Q2 		$128M Sell
2,202,971
-30,207
-1% -$1.62M 1.76% 15
2020
Q1 		$88M Sell
2,233,178
-704,241
-24% -$41.2M 1.42% 25
2019
Q4 		$175M Buy
2,937,419
+1,944,215
+196% +$105M 1.88% 14
2019
Q3 		$52.8M Sell
993,204
-17,340
-2% -$890K 0.9% 49
2019
Q2 		$51.6M Buy
1,010,544
+86,125
+9% +$4.01M 0.9% 48
2019
Q1 		$47.8M Sell
924,419
-175,680
-16% -$8.52M 0.86% 52
2018
Q4 		$43.3M Sell
1,100,099
-233,930
-18% -$10.9M 0.88% 50
2018
Q3 		$68.8M Buy
1,334,029
+13,999
+1% +$685K 1.17% 43
2018
Q2 		$61.9M Sell
1,320,030
-25,410
-2% -$1.05M 1.11% 42
2018
Q1 		$47.8M Buy
1,345,440
+42,470
+3% +$1.66M 0.89% 51
2017
Q4 		$56.8M Buy
1,302,970
+645,760
+98% +$30.2M 1.03% 46
2017
Q3 		$34.4M Buy
657,210
+349,510
+114% +$19.5M 0.64% 63
2017
Q2 		$18M Buy
+307,700
New +$16M 0.35% 75

Other funds holding SYNH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Nomura Holdings
Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Cooke & Bieler's SYNH Position: Q1 2023 in Review

Cooke & Bieler sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2023, closing a stake of 1,882,572 shares — an estimated $69.1M sold.

Cooke & Bieler first reported a position in SYNH in Q2 2017 and held it in 23 quarters. The position peaked at $203M in Q2 2022. 305 funds tracked by Wall St. Rank hold SYNH as of Q1 2023.

  • Cooke & Bieler reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q1 2023 after selling out during the quarter.
  • Cooke & Bieler sold 1,882,572 Syneos Health, Inc. Class A Common Stock shares in Q1 2023, an estimated $69.1M.
  • Cooke & Bieler first reported a position in Syneos Health, Inc. Class A Common Stock in Q2 2017 and held it in 23 quarters.
  • Cooke & Bieler's Syneos Health, Inc. Class A Common Stock position peaked at $203M in Q2 2022.
  • 305 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2023.

Based on Cooke & Bieler's 13F filing for Q1 2023, filed 8 May 2023.